Emergence of Clinically Macrolide-Unresponsive <i>Mycoplasma pneumoniae</i> Segmental/Lobar Pneumonia and COVID-19 Pneumonia in Children in Taiwan, 2024–2025

<b>Background:</b> To date, no study has compared the clinical characteristics of <i>Mycoplasma pneumoniae</i>-associated segmental/lobar pneumonia, <i>Mycoplasma</i> bronchopneumonia, and COVID-19 pneumonia primarily caused by the NB.1.8.1 variant in children. <b>Methods</b>: We examined the epidem...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Hao-Yuan Lee, Chien-Chin Chen, Shu-Hua Ko, Yu-Ling Huang, En-Pen Chang, Cheng-Yi Hsu, Jia Ru Wu, Wei-Hsin Chen, Yu-Chau Hsu, Meng-Yen Li, Yu-Lung Hsu, Wen-Yuan Lee, Chyi-Liang Chen
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2026-03-01
Rangatū:	Antibiotics
Ngā marau:	macrolide doxycycline <i>Mycoplasma pneumoniae</i> COVID-19
Urunga tuihono:	https://www.mdpi.com/2079-6382/15/3/292
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!